Background/Aims Serum hepatitis B virus (HBV) DNA levels and non-invasive liver fibrosis scores are significantly associated with hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. Nonetheless, the relationship between HBV DNA levels and liver fibrosis scores is unclear.
Methods A historical cohort comprising 6,949 non-cirrhotic Korean CHB patients without significant alanine aminotransferase elevation was investigated. The association of HBV DNA levels with the aspartate aminotransferase to platelet ratio index (APRI) and fibrosis (FIB)-4 score at baseline was analyzed using general linear models.
Results In HBeAg-negative patients (n=4,868), HBV DNA levels correlated linearly with both APRI and FIB-4 scores. In contrast, in HBeAg-positive patients (n=2,081), HBV DNA levels correlated inversely with both APRI and FIB-4 scores. Across the entire cohort, a significant non-linear parabolic relationship was identified between HBV DNA levels and fibrosis scores, independent of age and other covariates. Notably, moderate viral loads (6–7 log10 IU/mL) corresponded to the highest APRI and FIB-4 scores (p<0.001). Over a median 10-year follow-up, 435 patients (6.3%) developed HCC. Higher APRI scores ≥0.5 and FIB-4 scores ≥1.45 were significantly associated with elevated HCC risk (p<0.001 for both). HBV DNA level remained a significant predictive factor for HCC development, even after adjusting for APRI or FIB-4 scores.
Conclusions HBV viral load is significantly correlated with APRI and FIB-4 scores, and is also associated with HCC risk independent of those scores in CHB patients. These findings suggest that HBV DNA level is associated with hepatocarcinogenesis through both direct and indirect pathways.
Citations
Citations to this article as recorded by
Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis B Tao Fan, Jian Wang, Li Zhu, Ye Xiong, Shaoqiu Zhang, Jiacheng Liu, Chao Jiang, Shengxia Yin, Xin Tong, Guiyang Wang, Bei Jia, Juan Xia, Xiaomin Yan, Renling Yao, Yuxin Chen, Yu Shi, Xingxiang Liu, Yuanwang Qiu, Taoran Geng, Qun Zhang, Chuanwu Zhu, Chao Wu Digestive and Liver Disease.2026;[Epub] CrossRef
An interpretable machine learning model for prediction of significant liver fibrosis in comorbid chronic hepatitis B and nonalcoholic fatty liver disease: a retrospective development and validation study Jiaping Gu, Jiale Chai BMC Gastroenterology.2026;[Epub] CrossRef
Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B” Jian Wang, Shaoqiu Zhang, Chuanwu Zhu, Yuanwang Qiu, Chao Wu, Rui Huang Clinical and Molecular Hepatology.2025; 31(1): e27. CrossRef
Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B” Gi-Ae Kim, Seung Won Choi, Young-Suk Lim Clinical and Molecular Hepatology.2025; 31(1): e108. CrossRef
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial Young-Suk Lim, Ming-Lung Yu, Jonggi Choi, Chi-Yi Chen, Won-Mook Choi, Wonseok Kang, Gi-Ae Kim, Hyung Joon Kim, Yun Bin Lee, Jeong-Hoon Lee, Neung Hwa Park, So Young Kwon, Soo Young Park, Ji Hoon Kim, Gwang Hyeon Choi, Eun Sun Jang, Chien-Hung Chen, Yao-Ch The Lancet Gastroenterology & Hepatology.2025; 10(4): 295. CrossRef
Aspartate aminotransferase-to-platelet ratio index as a novel predictor of early mortality in heat stroke patients: a multi-centre retrospective study Min Wang, Yun Li, Yuan Cao, Meng-Meng Yang, Fu-Jing Liu, Jie Jiao, Sheng-Yuan Wang, Bin Song, Lu Wang, Yi-Qi Wu, Hong-Jun Kang Annals of Medicine.2025;[Epub] CrossRef
Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis Nobuharu Tamaki, Daniel Q. Huang, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Dong Hyun Sinn, Tae Seop Lim, Hiroyuki Marusawa, Seng Gee Lim, Hironori Ochi, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Masayuki Kurosaki, Beom Kyung K Journal of Gastroenterology and Hepatology.2025; 40(6): 1595. CrossRef
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection Markus Cornberg, Lisa Sandmann, Jerzy Jaroszewicz, Patrick Kennedy, Pietro Lampertico, Maud Lemoine, Sabela Lens, Barbara Testoni, Grace Lai-Hung Wong, Francesco Paolo Russo Journal of Hepatology.2025; 83(2): 502. CrossRef
Geospatial patterns and socioeconomic determinants of the global acute viral hepatitis burden Ke-Jie He, Guoyu Gong Frontiers in Public Health.2025;[Epub] CrossRef
Evaluating Non-Invasive Biomarkers and Composite Scores for Liver Fibrosis Diagnosis in Hepatitis B and C Infections Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Ayman E. El Agroudy, Yuliang Wang SN Comprehensive Clinical Medicine.2025;[Epub] CrossRef
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B Gi-Ae Kim, Young-Suk Lim Annals of Internal Medicine.2025; 178(9): 1365. CrossRef
Integrated Assessment of Liver Disease Severity and Viral Load in Human Immunodeficiency Virus–Hepatitis B Virus Coinfected Individuals: Utilizing Aspartate Aminotransferase/Platelet Ratio Index and FIB-4 Biomarkers Alongside Real-time Polymerase Chain Re Hiba Sami, Mohd Asaad, Sohail Ansari, Syed Haider Mehdi Husaini, Mohammad Azam Khan, Parvez Anwar Khan, Nazish Fatima, Haris Manzoor Khan Journal of Applied Sciences and Clinical Practice.2025; 6(3): 89. CrossRef
Revised REACH-B Model for Hepatocellular Carcinoma Risk Prediction in Patients With Chronic Hepatitis B Ju Dong Yang, Patrick S. Kamath Annals of Internal Medicine.2024; 177(10): 1435. CrossRef
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection Kazuto Tajiri, Yuka Hayashi, Aiko Murayama, Nozomu Muraishi, Masami Minemura, Ichiro Yasuda Viruses.2024; 17(1): 44. CrossRef
First
Prev
